These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1699613)

  • 1. Effects of low-dose 4-fluorotranylcypromine on rat brain monoamine oxidase and neurotransmitter amines.
    Sherry RL; Baker GB; Coutts RT
    Biol Psychiatry; 1990 Sep; 28(6):539-43. PubMed ID: 1699613
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic effects of tranylcypromine and 4-fluorotranylcypromine on regional brain monoamine metabolism in rats: a comparison with clorgyline.
    Greenshaw AJ; Rao TS; Nazarali AJ; Baker GB; Coutts RT
    Biol Psychiatry; 1989 Apr; 25(8):1014-20. PubMed ID: 2470425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Methoxytranylcypromine, a monoamine oxidase inhibitor: effects on biogenic amines in rat brain following chronic administration.
    Sherry-McKenna RL; Baker GB; Mousseau DD; Coutts RT; Dewhurst WG
    Biol Psychiatry; 1992 May; 31(9):881-8. PubMed ID: 1353376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ring-substituted analogues of tranylcypromine as monoamine oxidase inhibitors.
    Sherry RL; Baker GB; Coutts RT; Mousseau DD
    J Neural Transm Suppl; 1990; 32():107-12. PubMed ID: 1982446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ischemia on hydroxylase cofactor (tetrahydrobiopterin) and monoamine neurotransmitters in rat brain.
    Iijima S; Hara K; Suga H; Nakamura S; Kameyama M
    Stroke; 1986; 17(3):529-33. PubMed ID: 2424155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the mechanism of action of caroxazone, a new antidepressant drug.
    Moretti A; Caccia C; Calderini G; Menozzi M; Amico A
    Biochem Pharmacol; 1981 Oct; 30(19):2728-31. PubMed ID: 6170295
    [No Abstract]   [Full Text] [Related]  

  • 7. Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels.
    Griebel G; Curet O; Perrault G; Sanger DJ
    Neuropharmacology; 1998 Jul; 37(7):927-35. PubMed ID: 9776388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of monoaminergic neurotransmitters in fetal and postnatal rat brain: analysis by HPLC with electrochemical detection.
    Herregodts P; Velkeniers B; Ebinger G; Michotte Y; Vanhaelst L; Hooghe-Peters E
    J Neurochem; 1990 Sep; 55(3):774-9. PubMed ID: 1696620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical and neuropharmacological properties of 4-fluorotranylcypromine.
    Coutts RT; Rao TS; Baker GB; Micetich RG; Hall TW
    Cell Mol Neurobiol; 1987 Sep; 7(3):271-90. PubMed ID: 3440283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function.
    McKenna KF; Baker GB; Coutts RT; Greenshaw AJ
    J Pharm Sci; 1992 Aug; 81(8):832-5. PubMed ID: 1383493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
    Kato T; Dong B; Ishii K; Kinemuchi H
    J Neurochem; 1986 Apr; 46(4):1277-82. PubMed ID: 2419508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotransmitters in the brains of patients with dementia disorders.
    Gottfries CG
    Dan Med Bull; 1985 Feb; 32 Suppl 1():44-8. PubMed ID: 2580668
    [No Abstract]   [Full Text] [Related]  

  • 13. Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism.
    Carlsson A; Adolfsson R; Aquilonius SM; Gottfries CG; Oreland L; Svennerholm L; Winblad B
    Adv Biochem Psychopharmacol; 1980; 23():295-304. PubMed ID: 6156586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of praziquantel on monoamine transmitters in the rat brain].
    Liu GQ; Ma ZQ; Yang XJ; Jiang Y; Xie L
    Yao Xue Xue Bao; 1985 Nov; 20(11):807-10. PubMed ID: 2424264
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in rat brain monoamine turnover following chronic antidepressant administration.
    Sugrue MF
    Life Sci; 1980 Feb; 26(6):423-9. PubMed ID: 6154860
    [No Abstract]   [Full Text] [Related]  

  • 16. Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action.
    Fon EA; Pothos EN; Sun BC; Killeen N; Sulzer D; Edwards RH
    Neuron; 1997 Dec; 19(6):1271-83. PubMed ID: 9427250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain concentrations of biogenic amines and their metabolites in two types of pyrogen-induced fever in rabbits.
    Gardey-Levassort C; Tanguy O; Lechat P
    J Neurochem; 1977 Jan; 28(1):177-82. PubMed ID: 13153
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of extracts from St. John's Wort and Kava Kava on brain neurotransmitter levels in the mouse.
    Serdarevic N; Eckert GP; Müller WE
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S134-6. PubMed ID: 11518062
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis.
    Pieri L; Keller HH; Burkard W; Da Prada M
    Nature; 1978 Mar; 272(5650):278-80. PubMed ID: 203869
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma 5-hydroxyindoleacetic acid as an indicator of monoamine oxidase-A inhibition in rat brain and peripheral tissues.
    Celada P; Artigas F
    J Neurochem; 1993 Dec; 61(6):2191-8. PubMed ID: 7504085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.